Status
Conditions
Treatments
About
The aim of the current study is to investigate whether daily intake of Nordic berries for 12 weeks can improve cognitive abilities of adults with mild cognitive impairment, and whether the effect can be linked to changes in metabolic parameters.
Full description
The study will be conducted with a randomized, double-blind, parallel-group (2 arms) placebo-controlled, single-center interventional design. The aim is to investigate the effects on cognitive function and cardiometabolic risk markers after 12 weeks intake of a berry product vs. a reference product. The reference will be isocaloric and matched in taste, appearance, volume and macronutrient composition to the active berry product.
Two groups, each of 50 volunteers, are studied. Volunteers will be patients attending the Cognitive medicine unit at Ängelholm hospital, who have mild cognitive impairment (but not dementia). One group of volunteers will consume the berry product while the other group act as control and will consume the reference product.
Each volunteer will be seen for a screening visit as well as one pre- and one post-intervention visit at the clinic. In addition, there will be 2 follow-up calls in between visits. Pre- and post-intervention visits will include cognitive assessment with the CANTAB battery (episodic memory and verbal recognition memory), as well as additional cognitive and behavioral tests. Cardiometabolic parameters will be addressed (plasma glucose, insulin, inflammatory markers, blood lipids, body composition) and fecal samples collected.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
MMSE (Mini-Mental State Examination) <24 (at screening or in the last 3 months).
Cognitive disease (e.g. dementia) according to Global Deterioration Scale (GDS) stage 4 and up.
Severe affective disorder with current symptoms
Severe mental disorder.
Newly diagnosed or poorly regulated thyroid disease (unstable dose since 3 months back).
Ongoing insulin therapy.
Ongoing treatment for malignancy*.
Conditions with major impact on the gastrointestinal tract (such as Crohn's disease, ulcerative colitis, diagnosed gluten intolerance, undertaken intestinal resection or weight loss surgery).
Planned major intervention in health care over the next 3 months (the study period).
Undergoing antibiotic therapy for the last 3 months prior to inclusion in the study.
Allergy / intolerance to berries or other ingredients in the study products (i.e., colorants, aromas, starch).
Vegetarians / vegans.
Smoking.
Abuse of alcohol or psychoactive substance.
Significant change in medication over the last 3 months.
Daily, regular high consumption of berries or juices / marmalade / product with high content of these berries (guideline no more than 5 grams per day). (Can be recruited for the study if this intake ceases before visit 1. High consumes (approximately 1 dl of berries per day) has to cease with this at least one month before visit 1.)
Taking supplements with potential cognitive effects (e.g. omega-3, ginko biloba), or containing grape and berry extracts or probiotics (capsules or other). (Can be recruited if this intake ceases at least one month before visit 1).
Planned longer absence/vacation during the next 3 months (the study period).
Concurrent participation in other clinical intervention trials (dietary/pharmacological).
Other reasons that make the Study investigator in consultation with the responsible physician deem the person inappropriate to include.
Primary purpose
Allocation
Interventional model
Masking
96 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal